THE SHARE: Change: +0.00 SEK (+0.83%) / Price: 0.12 SEK / Mar 16, 2026, 11:27 am (CET)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Spago Nanomedical in media

  • 17 Nov, 2016
    Film från presentation vid Stora Aktiedagen 2016-11-14
  • 29 Sep, 2016
    Film från bolagspresentation vid Redeye Investor Forum i Göteborg 2016-09-22
  • 21 Sep, 2016
    Spago Nanomedical presenterar på Redeye Investor Forum
  • 15 Sep, 2016
    Pilot study suggest role of MRI in primary screening for prostate cancer
  • 15 Sep, 2016
    Pilotstudie pekar på möjligheten att använda MRI-screening för prostatacancer
  • 19 Aug, 2016
    Andreas Gram appointed Production Manager
  • 19 Aug, 2016
    Andreas Gram utsedd till Production Manager
  • 27 May, 2016
    Spago Nanomedical lanserar ny hemsida och grafisk profil
  • 27 May, 2016
    Spago Nanomedical launches new website and visual identity
  • 12 May, 2016
    Mats Hansen om Spago Nanomedicals verksamhet
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 19
  • Previous
  • Next
Back
  • Spago Nanomedical in media
  • Press Releases
  • Subscribe
  • Presentations
  • Events
  • Image Bank

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications